Susquehanna International Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.3M | Sell |
1,186,035
-2,572,047
| -68% | -$68.5M | ﹤0.01% | 1632 |
|
|
2025
Q4 | $93.6M | Sell |
3,758,082
-8,837,922
| -70% | -$223M | 0.01% | 929 |
|
|
2025
Q3 | $321M | Buy |
12,596,004
+1,069,039
| +9% | +$26.4M | 0.04% | 392 |
|
|
2025
Q2 | $279M | Buy |
11,526,965
+887,751
| +8% | +$20.7M | 0.04% | 357 |
|
|
2025
Q1 | $270M | Buy |
10,639,214
+1,102,688
| +12% | +$28.9M | 0.05% | 318 |
|
|
2024
Q4 | $253M | Sell |
9,536,526
-752,196
| -7% | -$20.4M | 0.04% | 353 |
|
|
2024
Q3 | $298M | Buy |
10,288,722
+1,223,710
| +13% | +$35.7M | 0.05% | 290 |
|
|
2024
Q2 | $254M | Sell |
9,065,012
-5,814,161
| -39% | -$160M | 0.05% | 292 |
|
|
2024
Q1 | $413M | Sell |
14,879,173
-2,968,135
| -17% | -$82.4M | 0.07% | 213 |
|
|
2023
Q4 | $514M | Buy |
17,847,308
+10,947,182
| +159% | +$331M | 0.1% | 162 |
|
|
2023
Q3 | $229M | Buy |
6,900,126
+2,469,709
| +56% | +$87.3M | 0.05% | 301 |
|
|
2023
Q2 | $163M | Sell |
4,430,417
-4,217,985
| -49% | -$164M | 0.03% | 412 |
|
|
2023
Q1 | $353M | Buy |
8,648,402
+6,382,870
| +282% | +$276M | 0.08% | 209 |
|
|
2022
Q4 | $116M | Buy |
2,265,532
+1,794,154
| +381% | +$86M | 0.03% | 495 |
|
|
2022
Q3 | $20.6M | Sell |
471,378
-850,022
| -64% | -$41.3M | 0.01% | 1403 |
|
|
2022
Q2 | $69.3M | Sell |
1,321,400
-109,046
| -8% | -$5.56M | 0.02% | 674 |
|
|
2022
Q1 | $74.1M | Sell |
1,430,446
-363,137
| -20% | -$18.8M | 0.01% | 807 |
|
|
2021
Q4 | $106M | Sell |
1,793,583
-4,416,414
| -71% | -$219M | 0.02% | 692 |
|
|
2021
Q3 | $267M | Sell |
6,209,997
-2,295,974
| -27% | -$102M | 0.04% | 408 |
|
|
2021
Q2 | $333M | Sell |
8,505,971
-1,143,813
| -12% | -$44.5M | 0.05% | 330 |
|
|
2021
Q1 | $350M | Sell |
9,649,784
-980,592
| -9% | -$34.8M | 0.06% | 289 |
|
|
2020
Q4 | $391M | Buy |
10,630,376
+390,479
| +4% | +$14.3M | 0.06% | 228 |
|
|
2020
Q3 | $357M | Sell |
10,239,897
-545,838
| -5% | -$19.1M | 0.07% | 211 |
|
|
2020
Q2 | $335M | Buy |
10,785,735
+4,234,163
| +65% | +$144M | 0.08% | 196 |
|
|
2020
Q1 | $203M | Buy |
6,551,572
+3,983,458
| +155% | +$136M | 0.06% | 226 |
|
|
2019
Q4 | $95.5M | Buy |
2,568,114
+964,192
| +60% | +$34.3M | 0.03% | 505 |
|
|
2019
Q3 | $54.7M | Buy |
1,603,922
+1,283,882
| +401% | +$46.7M | 0.02% | 682 |
|
|
2019
Q2 | $13.2M | Buy |
320,040
+227,944
| +248% | +$9.05M | ﹤0.01% | 1629 |
|
|
2019
Q1 | $3.71M | Buy |
+92,096
| New | +$3.69M | ﹤0.01% | 2836 |
|
|
2018
Q4 | – | Sell |
-24,341
| Closed | -$1.01M | – | 9715 |
|
|
2018
Q3 | $1.02M | Sell |
24,341
-63,320
| -72% | -$2.44M | ﹤0.01% | 5170 |
|
|
2018
Q2 | $3.02M | Buy |
87,661
+4,861
| +6% | +$166K | ﹤0.01% | 3376 |
|
|
2018
Q1 | $2.79M | Buy |
+82,800
| New | +$2.85M | ﹤0.01% | 3369 |
|
|
2017
Q4 | – | Sell |
-592,028
| Closed | -$20.2M | – | 9736 |
|
|
2017
Q3 | $20.1M | Sell |
592,028
-898,880
| -60% | -$28.9M | 0.01% | 1226 |
|
|
2017
Q2 | $47.5M | Sell |
1,490,908
-2,364,860
| -61% | -$74.6M | 0.02% | 636 |
|
|
2017
Q1 | $125M | Buy |
3,855,768
+884,433
| +30% | +$27.9M | 0.06% | 266 |
|
|
2016
Q4 | $91.6M | Buy |
2,971,335
+2,041,391
| +220% | +$62.3M | 0.05% | 358 |
|
|
2016
Q3 | $29.9M | Buy |
929,944
+578,227
| +164% | +$19.3M | 0.01% | 766 |
|
|
2016
Q2 | $11.8M | Sell |
351,717
-5,124,284
| -94% | -$164M | 0.01% | 1325 |
|
|
2016
Q1 | $154M | Buy |
5,476,001
+1,857,738
| +51% | +$53.1M | 0.08% | 196 |
|
|
2015
Q4 | $111M | Buy |
3,618,263
+1,963,109
| +119% | +$61.8M | 0.05% | 327 |
|
|
2015
Q3 | $49.3M | Sell |
1,655,154
-1,126,786
| -41% | -$36.1M | 0.02% | 634 |
|
|
2015
Q2 | $88.5M | Buy |
2,781,940
+1,201,815
| +76% | +$39.2M | 0.04% | 458 |
|
|
2015
Q1 | $52.2M | Sell |
1,580,125
-175,489
| -10% | -$5.58M | 0.02% | 610 |
|
|
2014
Q4 | $51.9M | Sell |
1,755,614
-4,046,760
| -70% | -$116M | 0.02% | 708 |
|
|
2014
Q3 | $163M | Sell |
5,802,374
-2,353,186
| -29% | -$66M | 0.06% | 266 |
|
|
2014
Q2 | $230M | Buy |
8,155,560
+3,608,097
| +79% | +$103M | 0.1% | 158 |
|
|
2014
Q1 | $139M | Buy |
4,547,463
+1,582,528
| +53% | +$47.2M | 0.06% | 262 |
|
|
2013
Q4 | $86.2M | Sell |
2,964,935
-729,866
| -20% | -$21.2M | 0.04% | 406 |
|
|
2013
Q3 | $101M | Sell |
3,694,801
-32,615,407
| -90% | -$887M | 0.05% | 305 |
|
|
2013
Q2 | $965M | Buy |
+36,310,208
| New | +$1B | 0.55% | 13 |
|
Other funds holding PFE
VCM
VPM
Susquehanna International Group's PFE Position: Q1 2026 in Review
Susquehanna International Group reduced its Pfizer (PFE) stake by 68% in Q1 2026, selling an estimated $68.5M and leaving 1,186,035 shares worth $33.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
Susquehanna International Group first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $965M in Q2 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Susquehanna International Group held 1,186,035 shares of Pfizer worth $33.3M as of Q1 2026.
- Susquehanna International Group sold 2,572,047 Pfizer shares in Q1 2026, an estimated $68.5M.
- Pfizer made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1632 holding.
- Susquehanna International Group first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's Pfizer position peaked at $965M in Q2 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.